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Autoinﬂammatory diseases are a heterogeneous group of congenital diseases characterized by the presence of recurrent inﬂam-
mation, in the absence of infectious agents, detectable autoantibodies or antigen-speciﬁc autoreactive T-cells. SHARPIN deﬁcient
mice presents multiorgan chronic inﬂammation without known autoantibodies or autoreactive T-cells, designated Sharpincpdm.
Histological studies demonstrated epidermal hyperproliferation, Th-2 inﬂammation, and keratinocyte apoptosis in this mutant.
The mutant mice have decreased behavioral mobility, slower growth, and loss of body weight. Epidermal thickness and mitotic
epidermal cells increase along with disease development. K5/K14 expression is distributed through all layers of epidermis, along
with K6 expression in interfollicular epidermis, suggesting epidermal hyperproliferation. K1/K10 is only detectable in outer layers
of spinosum epidermis, reﬂecting accelerated keratinocyte migration. Alpha smooth muscle actin is overexpressed in skin blood
vessels, which may release the elevated white blood cells to dermis. CD3+CD45+ cells and granulocytes, especially eosinophils and
mast cells, aggregate in the mutant skin. TUNEL assay, together with Annexin-V/propidium iodide FACS analysis, conﬁrmed
the increase of apoptotic keratinocytes in skin. These data validate and provide new lines of evidence of the proliferation-
inﬂammation-apoptosistriad in Sharpincpdm mice, an NFκB activation autoinﬂammatorydisease.
1.Introduction
The relatively new term of “autoinﬂammatory disease”
appeared in the pages of “Cell” in the spring of 1999 to
denote an emerging group of heritable disorders charac-
terized by two negatives, the lack of apparent provoca-
tion of seemingly unprovoked inﬂammation, and the ab-
sence of high-titer autoantibodies or antigen-speciﬁc T cells
[1, 2]. Although diﬀerent from autoimmune diseases, au-
toinﬂammatory and autoimmune diseases share common
characteristics in that both groups of disorders result from
the immune system attacking the body’s own tissues and
also result in increased inﬂammation. Simply put, the au-
toinﬂammatory diseases are clinical disorders marked by
abnormally increased inﬂammation, mediated predomi-
nantly by the cells and molecules of the innate immune
system, with a signiﬁcant host predisposition [3]. The
molecularpathophysiologyoftheautoinﬂammatory diseases
has been a topic of growing clinical interest. Positional
cloningandcandidategeneanalysishaveprovidedimportant
insights to the monogenic autoinﬂammatory diseases. In the
last decade, common variants by genome-wide association
studies have been detected as the genetic basis of complex
autoinﬂammatory diseases. The recently discovered genetic
bases of autoinﬂammatory diseases have been linked to
the mutations in genes encoding a relatively new family
of proteins that have important roles in the regulation of
apoptosis, inﬂammation, and cytokine processing [4]. A
good example in this context is the association of CARD15
and NOD2 variations with the Blau syndrome and Crohn’s
disease [5, 6].
Chronic proliferative dermatitis mutant (cpdm)m i c e
are characterized by multiorgan inﬂammation initially rec-
ognized as erythematous, scaly areas of alopecia at 3-4
weeks of age [7]. Both clinical features and histological
changes, such as epidermal hyperplasia and severe dermal
inﬂammation, made investigators have taken cpdm mice
as a model of human psoriasis, hence alternatively named2 Pathology Research International
“psoriasiform dermatitis” [8, 9]. Even considering the
anatomic and biological diﬀerences between human and
mouse [10], normal keratinocyte diﬀerentiation [11], Th2
but not Th1 inﬂammation [12], and diﬀerent malfunc-
tions of involved organs suggested Sharpincpdm mice do
not indeed resemble human psoriasis. Beside dermati-
tis, hepatosplenomegaly, pneumonia, lymphadenitis, upper
gastrointestinal eosinophilic inﬂammation, and osteopenic
phenotype are also severe symptoms in Sharpincpdm mice
[13–15]. Persistent eosinophilia, multisystem eosinophil
inﬁltration, aberrant CD3−CD4+ cells, equivalent sex ratio,
and Th2-type inﬂammation suggested Sharpincpdm mutant
may be more likely as a mouse model for the lymphocytic
variant of hypereosinophilic syndrome (LHES) [14].
Positional cloning studies identiﬁed two independent,
spontaneous autosomal recessive mutations in the mice that
were null for the Sharpin gene product as the genomic defect
of this phenotype [13]. SHARPIN is widely expressed in
multiple tissues in human and mice [16]. Protein motif
search suggested three important functional domains of
SHARPIN, the Hoil1-N domain of ubiquitination activity,
regionAA172-305interactingwithSHANK1,andCterminal
RanBP domain associated with nuclear transport. A yeast
two-hybrid (Y2H) screen with TRAF2 (TNF receptor-asso-
ciated factor 2) as the bait (UCSDNature Signaling Gateway,
data center, yeast two-hybrid, http://www.signaling-gateway
.org/data/Y2H/cgi-bin/y2h int.cgi?id=53738)h a si d e n t i ﬁ e d
SHARPIN (alternative symbol: protein kinase C-interacting
protein RBCC like 1 (RBCKL1)) is one of its preys in B cell
lines. Protein immunoprecipitation identiﬁed SHARPINhas
interaction with TRAF2 and negatively regulates TRAF2-
mediated NFκBa c t i v i t y[ 17]. Inhibition of NFκB signaling
can signiﬁcantly alleviate the skin problems in Sharpincpdm
mice [14].
Many physiological processes, including proper tissue
development and homeostasis, require a balance between
apoptosis and cell proliferation. All somatic cells proliferate
via a mitotic process determined by progression through the
cellcycle.Apoptosisandprogramcelldeath(PCD)isagenet-
ically regulated, cellular suicide mechanism which occurs
in a wide variety of physiological settings, where its role is
to remove harmful, damaged, or unwanted cells. Apoptosis
and cell proliferation are linked by cell-cycle regulators and
apoptotic stimuli that aﬀect both processes [18]. Imbalance
of proliferation and apoptosis is commonly seen in various
skin diseases such as psoriasis and sunburn [19]. In mam-
malian cells, a variety of apoptotic stimuli induce a series of
biochemical reactions that imbalance the ratio of proapop-
totic/antiapoptotic (e.g., Bax/Bcl2 ratio) proteins between
the mitochondria and cytosol and then disturb energy me-
tabolism resulting mitochondria defect by releasing death
factors into the cytosol and then leading to the formation of
apoptosomeandactivationofcaspasesresultinginapoptosis.
The spontaneous null mutation of Sharpin(Sharpincpdm)
causes mice to undergo abnormal epithelial cell death in the
skin, esophagus, and forestomach [20]. As the balance of
epidermal hyperproliferation, increased cleaved caspase-3
positive apoptotic keratinocytes were found in Sharpincpdm
skin with mitochondria defect [21].
The present study adds new lines of evidence of inﬂam-
mation, proliferation, and apoptosis in the skin of Sharp-
incpdm mice, a good tool to study NFκBa c t i v a t i o na u t o i n -
ﬂammatory diseases.
2.Materialsand Methods
2.1. Mice. C57BL/KaLawRij-Sharpincpdm/RijSunJ (JR no.
007599), and B6; 129S1-Il1raptm1Roml/J (JR no. 003284) mice
were maintained in a humidity, temperature, and light cycle
(12:12) controlled vivarium under speciﬁc pathogen-free
conditions(http://jaxmice.jax.org).Sharpincpdmmiceofboth
sexes are equally aﬀected. As female mutant mice do not
breed, they were used for all experiments unless indicated
otherwise. Mice were housed in double-pen polycarbonate
cages at a maximum capacity of four mice per pen. Mice
were allowed free access to autoclaved food (NIH 31, 6%
fat; LabDiet 5K52, Purina Mills, St. Louis, Mo) and acidiﬁed
water (pH 2.8–3.2). All work was done with Institutional
Animal Care and Use Committee approval.
2.2. Antibodies. Rabbit antimouse ﬁlaggrin (no. PRB-417P),
keratin5(no.PRB-160P),keratin14(no.PRB-155P),keratin
1 (no. PRB-165P), keratin 10 (no. PRB-159P), and keratin 6
(no.PRB-169P)werefromCovance(Richmond,Calif,USA).
Monoclonal antialpha smooth muscle actin (no. A2547)
from mouse was from Sigma (Saint Louis, Miss, USA).
Rat antimouse Gr-1 (no. 550291), hamster antimouse CD3e
(no. 550277) and rat antimouse CD45RB (no. 553097) were
purchased from BDBiosciences(SanJose, Calif, USA).Alexa
Fluor 488 goat antirat IgG (no. A11006), Alexa Fluor 546
goat antihamster IgG (no. A2111) and Alexa Fluor 546 don-
key antigoat IgG (no. A11056) were purchased from Invit-
rogen Corporation (Carlsbad, Calif, USA). Horseradish per-
oxidase conjugatedgoatanti-rabbitIgG (no.32460)andrab-
bit anti-goat IgG (no. 31402) were from Thermo Scientiﬁc
(Rockford, Ill, USA).
2.3. Behavioral Tests. 10-week-old mice were placed at set
position in an open ﬁeld and allowed to explore for 10
seconds. Distance traveled, holes explored, time in center,
stretched attends, vertical explorations, number of fecal boli,
and number of urinations were automaticallyrecorded using
the SMART system from San Diego Instruments (San Diego,
Calif).
2.4. Immunohistochemistry. Dorsal skin was collected and
ﬁxed by immersion in Telly’s solution. Fixed tissues were
embedded routinely in paraﬃn and serially sectioned at
6μm.Forroutinehistopathologicalexamination, onesection
was deparaﬃnized, rehydrated, stained with hematoxylin
and eosin, and then dehydrated in an alcohol series, cleared
in Xylene, and mounted with Permount mounting media
entellan (Fisher Scientiﬁc, Pittsburgh, Pa, USA). One section
was stained with 0.5% acidiﬁed toluidine blue (in 0.5M
HCl; Merck, Germany) for 30 seconds. Twenty additional
serial sections were placed on poly-L-lysine-coated slides
for immunocytochemical staining. Paraﬃn sections werePathology Research International 3
stained with special dilution for each antibody (keratin 5
@ 1:500, keratin 14 @ 1:50, keratin 1 @ 1:2500, keratin
10 @ 1:1500, keratin 6 @ 1:2500, ﬁlaggrin @ 1:1500, alpha
smooth muscle actin @ 1:800, and caspase-3 @ 1:100).
2.5. Immunoﬂuorescence. Dorsal skin was embedded in cry-
oprotectant (Tissue-Tek O.C.T., Sakura Finetek USA, Tor-
rance, USA). Cryosections were prepared, ﬁxed in ice-cold
acetone, and blocked with 3% FBS (fetal bovine serum).
Sampleswerethensubjectedtoimmunoﬂuorescenceanalysis
by successive 2-hour long incubations with primary (Gr-
1 @ 1:100, CD3 @ 1:50, and CD45RB @ 1:100) and 1-
hour long with secondary antibodies (1:2000) and ﬁnally
counterstainedwithDAPI(1:10,000)for5minutes.Samples
were examined using a laser scanning confocal microscope
TCS-NT (Leica, Mannheim, Germany).
2.6. Complete Blood Counts. Whole blood (275μL) was
drawn from the retro-orbital sinus through EDTA-coated
microhematocrit tubes directly into Eppendorf tubes con-
taining 30μL 20% EDTA in PBS. The additional anticoag-
ulant is critical in preventingmicroclot formation. Complete
blood counts were determined immediately after obtain-
ing the samples using an Advia 120 Multispecies whole
blood analyzer (Bayer Corporation, Tarrytown, NY). Three
Sharpincpdm mutant and three +/+ control mice were used
for each time point.
2.7. Transmission Electron Microscopy (TEM). Strips of full-
thickness skin samples (5 × 10mm) were immersed imme-
diately at the time of necropsy in cold ﬁxative consisting
of 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1M
phosphate buﬀer (pH 7.2) and processed routinely. Pieces
of the strips (1 × 2mm) were transferred to fresh ﬁxative
overnight to 48 hours at 4◦C. After a brief rinse in phosphate
buﬀer, tissue specimens were postﬁxed in 2% phosphate-
buﬀered osmium tetroxide, dehydrated through a graded
series of EtOH, and embedded in Quetol 657 (EMS, Pa).
Semithick sections (0.5μm) were stained with toluidine
blue for light microscopy. Properly oriented blocks, with
full thickness epidermis and dermis present, were used for
ultrathin (100nm) sections. Ultrathin sections were stained
with uranyl acetate and lead citrate and examined in a
JEM-1230 transmission electron microscope (Jeol USA Inc.,
Peabody, Mass).
2.8. Apoptosis Assays In Vivo and In Vitro. Apoptosis was
evaluated on paraﬃn embedded sections of skin tissues by
Tdt-mediated dUTP nick-end labeling (TUNEL) using In
Situ Cell Death Detection Kit TMR red (Roche) per the
manufacturer instructions. Rehydrated tissues were treated
in 0.1M citrate buﬀer, pH 6.0 with 350W microwave
irradiation for 5min. Slides were then incubated with 50μL
of TdT incubation buﬀer at 37 ◦Cf o r6 0m i n u t e si n s i d e
a dark humid chamber. The reaction was terminated by
immersing the slides in 2x standard saline citrate for 15min.
The tissue orientation was determined by ﬁnal staining with
100ng/mL DAPI solution. Apoptotic cells were visualized
immediately with a confocal microscope, resulting in local-
ized red ﬂuorescence within the nucleus of the apoptotic
cells.
Epidermal KCs were prepared from 6-week-old mice
essentially per Lichti protocol [22]. For ﬂow cytometric
analysis, suspensions ofKCs(1 × 106)from 10week oldmice
were ﬁxed in 70% EtOH at 4◦C. After ﬁxation, cells were
permeabilizedwith0.01%TritonX-100andcentrifuged.The
pellets were resuspended in PBS and treated with PE conju-
gated Annexin-V and propidium iodide. Cells were count-
ed using ﬂow cytometry (BD Biosience). Approximately
25,000 events were acquired for analysis using Cell Quest
3.3 Software (BD Biosience). A histogram plot of FITC
ﬂuorescence (X a x i s )v e r s u sc o u n t s( Y axis) was generated
in logarithmic ﬂuorescence intensity.
2.9. Measurement of Epidermal Thickness, Mitotic, and Apop-
totic Keratinocytes. Epidermal thickness of 10 ﬁelds for each
sample, one sample per mouse and 3 mice per group, was
measured. Every ﬁeld includes at least one full-length hair
follicleasaninternalstandard fororientation.Theepidermal
thickness was measured from the basement membrane to
the top of the stratum granulosum. Mitotic and apoptotic
keratinocytes were counted from same ﬁelds of each sample.
2.10.Statistical Analysis. Datawere expressed asmeans ±SE.
Statistical comparisons between two groups were performed
bytheStudent’st-test.Statisticalsigniﬁcancewasdetermined
as P<. 05.
3.Results
3.1. Excess Body Weight Loss and Reduced Behavior Mobility
in SharpincpdmMutant Mice. As shown in Figures 1(a)–1(e),
hair loss and skin redness are usually recognized as ﬁrst
disease signs at the age of 2 weeks, and progressively become
worse. Skin scales can be found and then accumulate at the
erythematous areas. At the age of 8 weeks, skin appears to be
crackly and ulcerated initially from hair loss area around the
neck and foreleg and then spread to dorsal and ventral skin.
The erythematous lesions become pigmented and scaling
islands. Hairs are then broken from the skin surface, leaving
the hair follicles in skin, which make separation of epidermis
from dermis very diﬃcult. Aﬀected skin areas of 9-10 weeks
mutant are then covered by psoriasis-like white scales and
separated by deep ulcerations. Ophthalmoptosis and abscess
under the neck skin can also be found in some mutants.
Mutant females have congenital atresia of vagina (data
not shown) and, therefore, are used for experiments. Mice
showed poorer motor activity (2.38inch/s) than controls
(2.79inch/s).Mutantmicemostlystayattheinnerboardand
so track shorter length (23.86inches), which may contribute
to more hole visits (166) at the board central (Figures 2(a)
and 2(c)), compared to 27.9inches track and 102 visit
holes of controls (Figures 2(b) and 2(c)). The longitudinal
body weight of 3 pairs of mutant and healthy mice are
obtained once a week from the age of 4 weeks to 10 weeks
(Figure 1(m)). Sharpincpdm mutant mice keep growing from4 Pathology Research International
(a) (b) (c) (d) (e) (f)
(g) (h) (i) (j) (k) (l)
0
10
20
30
40
50
60
70
T
h
i
c
k
n
e
s
s
(
µ
m
) Epidermis thickness
Mutant
Control
2468 1 0
Age (week)
(m)
0
5
10
15
20
25
30
35
40
C
e
l
l
s
/
m
m
2
2468 1 0
Age (week)
Epidermal mitosis
Mutant
Wildtype
(n)
2468 1 0
Age (week)
0
50
100
150
200
250
300
350
400
Mutant
Control
C
e
l
l
s
/
m
m
2
Epidermal apoptosis
(o)
Age (week)
Mutant
Wildtype
0
5
10
15
20
25
5 4 6789 1 0
W
e
i
g
h
t
(
g
)
Body weight
(p)
Figure 1: Chronic hyperproliferative dermatitis with loss of body weight. Longitudinal macroscopic observations at 5 time points (2-, 4-,
6-, 8-, and 10-week) found progressive development of dermatitis in Sharpincpdm mutant mice (a)–(e), compared to the representative
of wildtype mice at the age of 10 weeks (f). Hair loss and skin redness can be carefully found at forehead in 2-week-old mutant and
gradually develop toward the posterior end of body. After the age of 6 weeks, pigmented skin islands formed containing broken hair shafts
in skin and inﬂammatory pigmentation, covered with small, scurfy scales. Skin openings occur at the hairless areas after 6 weeks of age
and gradually became deeper and wider until 10-week old. Histologically, increasing of epidermal thickness is consistent with the severity of
epidermalhyperproliferation (g)–(m).Keratinocyte mitosisandapoptosiswere quantitativelyanalyzedateachtimepoint(m,n).Compared
to wildtypes, the mutant mice present slower growth of body weight at the beginning of 4 weeks of age and lose body weight after 8 weeks of
age (p).
11.47g at 4-week age to 16.3g at the age of 8 weeks, and then
lose weight to 15.44g at 10-week age, when mice have to be
euthanizedregarding thediseaseseverity.Thewild-typemice
are signiﬁcantly bigger than the mutants from the age of 4
weeks (12.88g) and keep growing to 15.03g, 16.29g, 17.02g,
17.99g, 18.74g, and 19.71g, respectively, at 5-, 6-, 7-, 8-, 9-,
and 10-week age.
3.2. Severe Granulocyte Inﬁltration in the Skin of Sharpincpdm
Mutant Mice. Previous spectrum analysis of cytokines char-
acterized a Th-2 inﬂammation in the skin of Sharpincpdm
mice [12]. As shown in Figure 3(e), double immunoﬂuores-
cence staining using anti-CD3 (green) and anti-CD45 (red)
has identiﬁed increasing of CD3+ cells, or CD45+ cells, or
CD3+ CD45+ cells in the dermis of mutant mice, compared
to a few CD3+ cells in the skin of control (Figure 3(f)).
Cytokinesandchemokinessecreted byCD3+CD45+ helperT
cells may contribute to the formation of Th-2 inﬂammation.
The severity of inﬂammation is correlated with the over-
expression of alpha smooth muscle actin in the mutant skin
(Figures 3(a) and 3(b)). Toluidine blue staining conﬁrmed
huge increasing of mast cells in Sharpincpdm dermis (Figures
3(c) and 3(d)). The number and morphology of red blood
cells and platelets have no signiﬁcant changes (data not
shown). White blood cells in peripheral blood increase
dramatically at every disease stage (Figure 3(l)). The gran-
ulocytes (eosinophils, basophils, and neutrophils) increase
over 10-fold changes at average. Gr-1 positive inﬂammatory
cells dramatically migrate into and form clusters in the
mutant dermis (Figure 3(g)), while normally there are a
few Gr-1+ cells in the skin of healthy mice (Figure 3(h)).
Ultrastructure analysis have identiﬁed most of inﬁltrated
granulocytes in mutant skin are eosinophils (Figure 3(i)),
together with some mast cells (Figure 3(j)), and a fewPathology Research International 5
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Figure 2: Exploratory test showed reduced behavioral activities in Sharpincpdm mice. Mutant(a) and wild-type (b) mice were placed in open
ﬁeld with 16holes on the board. Track distance, track speed, and hole visits were automatically recorded in limited time (c).
neutrophils(Figure 3(k)).Basophilsarenotfoundintheskin
although it had 10 times of increasing in peripheral blood.
3.3. Increased Epidermal Thickness, Mitosis, Keratin, and Fil-
aggrin Expression in Mutant Skin. As shown in Figure 1(n),
theepidermalthicknessremains constantlyat10μma f t erth e
age of 2 weeks in the skin of normal mice. It keepsincreasing
along with disease development from 10.9μm at 2-week
stageto59.17μmat10-weekageinSharpincpdmmutantmice.
Correspondently, the mitotic basal cells increase slowly in
the skin of healthy controls, respectively, of 2.93, 6.88, 8.83,
10.96, and 12.14 cells per mm3 at 2-, 4-, 6-, 8-, and 10-
week age (Figure 1(o)). In comparison, huge increasing of
mitotic basal cells is observed in the Sharpincpdm mice, from
6.2cells/mm3 at 2-week point to 37.71cells/mm at 10-week
point.Intheskinlesion,theexpressionofkeratinocytediﬀer-
entiation markers in the skin of Sharpincpdm mice are repli-
cated here using antibodies provided by diﬀerent vendors,
compared to previous report. No quantitative differences in
the changes in keratins and ﬁlaggrin are found between the
2-week-old and 10-week-old mice. K5 is primarily expressed
in basal keratinocyte but also relatively lower in suprabasal
layers of the epidermis of Sharpincpdm mice (Figure 4(b)).
K14 expression is uniformly distributed in all epidermal
layers, without preferential expression in basal layer of the
epidermis of Sharpincpdm mice (Figure 4(d)). K1 is expressed
in the suprabasal layers of the epidermis of normal mice
(Figure 4(e)). However, K1 expression is only limited to the
superﬁcial cell layers of the stratum spinosum and inner
shoot of hair follicle (Figure 4(f)). K10 expression is located
in the suprabasal layers and outer shoot of hair follicle in
the wildtype mice (Figure 4(g)). On contrast, K10 is only
expressed in the superﬁcial layers of the stratum spinosum
and decreased expression in the hair follicle (Figure 4(h)).
K6 is expressed in the hair follicle but not in the epidermis
of skin of wild-type mice (Figure 4(i)). It is expressed in
all layers of epidermis and hair follicles of 10-week-old
Sharpincpdm mice (Figure 4(j)). Filaggrin is detectable in
granular layer of normal skin (Figure 4(k)). Its expression is
increased in the granular layer, with variant expression in the
spinous layer, of the Sharpincpdm mice (Figure 4(l)).
3.4. Increased Single Cell Apoptosis of Keratinocyte in the Epi-
dermis of SharpincpdmMutant Mice. As counterpart of hyper-
proliferation and/or inﬂammation, increased apoptosis bod-
ies in single epidermal cells were determined by H&E stain-
ing (arrowed in Figure 5(a)). Longitudinal quantitative anal-
ysis revealed epidermal keratinocytes death in Sharpincpdm
mutant skin increase geometrically from 13.5cells/mm3
(2-week age) to 64.97cells/mm3 (8-week age) and then
steeply rise to 203.82cells/mm3 at 10-week age(Figure 1(p)).
TUNEL staining conﬁrmed increasing of epidermal cell
apoptosis, most of which were hair follicle keratinocytes
(Figures 5(c) and 5(d)). However, TUNEL positive cells
are also seen in the dermis of both mutant and wild-type
mice, which is not detected by H&E staining, suggesting
some false-positive cells by TUNEL staining. Epidermal cells
from 6-week-old mutant and wild-type mice are isolated
and sorted by Annexin-V and propidium iodide. Viable cells
signiﬁcantly decrease to 45.9% in mutant skin, compared
to 81.9% viability in the matched control, indicating the
increasing of apoptotic and/or dead cells in the Sharpin-
defect skin (Figures 5(e) and 5(f)).
4.Discussion
Animal models are very important tools for studying the
pathogenesis of human skin diseases [23, 24]. Complete
phenotype analysis is ﬁrst step to correlate and/or ﬁnally
translate physiological or pathologic conditions. It has been
reported that loss of function of SHARPIN in mice results
in multiorgan inﬂammation, epidermal hyperproliferation,
and mitochondria-mediated keratinocyte apoptosis [7, 11,
12, 21]. The present study have conﬁrmed previous reports6 Pathology Research International
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Figure 3: Granulocytic inﬂammation in the skin of Sharpincpdm mice. (a, b): Alpha smooth muscle active was overexpressed in the skin
blood vessel of mutant mice (a), compared to that of control (b). (c, d): Toluidine blue staining demonstrated increased inﬁltration of mast
cells in the dermis of mutant mice (c). A few of mast cells present in the skin of healthy mice (d). (e, f): Increased T cells (Green, CD3e+)
migrate into the skin lesion of mutant mice, among which some are helper T cells (double positive, CD3e+CD45RB+)( e ) .Af e wC D 3 e +T
cells (Green), but no CD45RB+ T cells were detected in the normal control (f). (g)–(l): Gr-1+ granulocytes were clustered in the mutant
skin (g), compared a few in normal skin for physiological demands (h). Transmission electron microscopy found most granulocytes are
eosinophils (i), with moderate mast cells (j) and few neutrophils (k) although neutrophils had huge increase in peripheral blood (l).
and addednewlines ofevidencestosupport thesepathologic
events. These novel data provide helpful clues for under-
standing and translation of this severe autoinﬂammatory
disorder in mice.
An expanding spectrum of acute and chronic inﬂam-
matory diseases is considered “autoinﬂammatory” diseases.
This category of illness usually has a genetic defect, presents
widespread inﬂammation, and lacks high-titer autoantibod-
ies and antigen-speciﬁc T cells. Based upon underlying
molecularmechanisms [25],six groups of autoinﬂammatory
diseases were proposed as (1) IL-1β activation disorders, (2)
NFκB activation disorders, (3) protein folding disorders of
the innate immune system, (4) complement disorders, (5)
cytokine signaling disorders, and (6) macrophage activation
disorders. The most recent study identiﬁed IL1 signaling
was activated in the Sharpincpdm skin, and blockade of IL1
signaling by knockout of IL1RAP can signiﬁcantly alleviate
the dermatitis severity [14]. Moreover, NFκB signaling
was activated primarily by stimuli including IL1 signal-
ing, contributing to the development of skin problems in
Sharpincpdm mice, and NFκB inhibitor, bortezomib, showed
better therapy eﬀect for dermatitis and mouse survival. The
concentration of sera IgA, IgE, and IgG were signiﬁcantly
lower in Sharpincpdm mice [26]. No autoantibodies and
antigen-speciﬁc T cells were detected. Regarding the chronic
systemic inﬂammation, Sharpincpdm mutant mice may serve
as an autoinﬂammatory mouse model of IL1 activation or
NFκB activation disorders.
Chronic systemic inﬂammation has been found to at the
root of many serious disorders, such as atopic dermatitis and
psoriasis [27]. These “age-related” disorders are accompa-
nied by a pathological increase of inﬂammatory cytokines.
Type 2 inﬂammation was reported in the skin of Sharpincpdm
mice based on the increased expression of IL-4, IL-5, andPathology Research International 7
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Figure 4: Expression changes of keratin and ﬁlaggrin in skin. (a, b): K5 expression in the basal layer of the epidermis of 10-week-old wild-
type mice (a) but in the whole epidermis, preferentially in the basal layer, of 10-week-old Sharpincpdm mice (b). (c, d): K14 expression in
the basal layer of the epidermis of 10-week-old wild-type mice (c). K14 was uniformly expressed in the whole epidermis of 10-week-old
Sharpincpdm mice (d). (e, f): K1 expression locates in suprabasal layer of the epidermis of 10-week-old wild-type mice (e) but limited to the
outer layers of the stratum spinosum of 10-week-old Sharpincpdm mice (f). (g, h): K10 expression is located at the suprabasal layers of the
epidermis and hair follicle of 10-week-old wild-type mice (g) but limited to the outer layers of the stratum spinosum of the epidermis and
hair follicle of 10-week-old Sharpincpdm mice (h). (i, j): K6 is only expressed in the hair follicle of 10-week-old wild-type mice (i) but widely
expressed inboth hairfollicleandinterfollicleepidermis of10-week-old Sharpincpdm mice(j).(k,l):Filagginexpressioninthe granularlayers
of the epidermis of 10-week-old normaland mutant mice.
IL-13 and no change of IL-10 and TNF [12]. Of interest is
the increased inﬁltration of CD3e+CD45RB+ cells and the
gradual increase of this subset in the Sharpincpdm skin. This
subsetofcellsmayreﬂect accelerateddiﬀerentiationofnative
CD45RA T cells under the inﬂuence of inﬂammation as
suggested by the results on cytokine expression [28]. The
high proportion of inﬁltrated granulocytes was eosinophils
in Sharpincpdm skin. Depending on the cytokines present in
the microenvirohment, activated eosinophils can promote
either a Th2 or Th1 immune response and amplify inﬂam-
mation via autocrine fashion [29]. Considering apoptotic
cells can selectively suppress the Th1 cytokines in peripheral
blood mononuclear cells and shift the Th1/Th2 balance
toward Th2, apoptotic keratinocytesin Sharpincpdm skin may
contribute to or ignite the Th2 inﬂammation as a local pro-
moting factor [30]. A K14-cre conditional knockout mouse
model will be the key tool to answer this question.
Chronic inﬂammation in animals and man acts like a
tumor promoter, driving epithelial cell proliferation and
epithelial carcinogenesis [31]. In Sharpincpdm skin, mitotic
keratinocytes increase constantly over time, along with simi-
lar pattern of epidermal thickness. The increased expression
of K5 and K14 in the suprabasal layers indicates an increase
of the proliferative compartment of the epidermis of mutant
mice.Moreover,thepresenceofK6expressionintheinterfol-
licularepidermisofSharpincpdmmicesupportstheepidermal
hyperproliferation. The delayed expression of K1 and K10
in the outer layers of epidermis may reﬂect the accelerated
suprabasal migration of keratinocytes, contributing to the
excess accumulation of psoriasis-like white scales. Apop-
tosis balances proliferation to maintain epidermal thick-
ness, contributes to stratum corneum formation, and may
eliminate premalignant cells [32]. The disturbance between
proliferation and apoptosis results in tumorigenesis and
wound healing defect. Previous studies identiﬁed that loss of
function of SHARPIN lead to caspase-dependent apoptosis
via mitochondrial pathway [21]. In this present study, his-
tological morphology quantitative analysis found consistent
increasing apoptosis index in mutant mice as counterpart
of hyperproliferation. Interestingly, TUNEL assay found that
most of apoptotic keratinocytes located in the hair follicle,
reﬂecting the pathogenesis of hair loss in the mutant mice.
As hair loss is the ﬁrst recognizable phenotype, keratinocyte
apoptosis may serve as the primary drive of pathological8 Pathology Research International
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Figure 5: Increased keratinocyte apoptosis in the skin of Sharpincpdm mice. (a, b): Numerous apoptosis bodies in the epidermis and hair
follicles of 6-week-old Sharpincpdm mice (a). No apparent apoptosis bodies were identiﬁed in the matched normal skin (b). (c, d): TUNEL
immunoﬂuorescence demonstrated that most apoptotic cells were located in the hair follicles, and some in the suprabasal epidermis, of 6-
week-old Sharpincpdm mice (c). No TUNEL positive cells were found in the epidermis of normal skin (d). TUNEL positive cells also present
in the dermis of both mutant and normal skin. (e, f): Annexin-V/propidium iodide FACS analysis conﬁrmed apoptosis in the epidermis of
6-week-old mutants.15.2% and 18.9%of totalepidermal cells ofthe mutantmice were, respectively, late apoptotic oractually dead cells (e),
compared to 1.07% and 7.67% of the wild-type epidermal cells (f).
events in mutant skin. It is possible that loss of function
of SHARPIN results in mitochondria-mediated keratinocyte
apoptosis, which contributes to the formation of Th2 in-
ﬂammation and proliferation. Furthermore, the loss of body
weight of the mutant may be consequence of the progressive
loss of hairs (alopecia) and excess water loss from the
disrupted skin barrier function.
5.Conclusion
The results of these studies provide novel clinical and
molecular data of the Sharpincpdm mutant mice and validate
the pathological triad of inﬂammation, proliferation, and
apoptosis in the skin of Sharpincpdm mice. Sharpincpdm mice
may be a good tool to study NFκB activation autoinﬂamma-
tory diseases.
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